A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Conditions: Respiratory Syncytial Virus

Interventions: Biological: mRNA-1345; Biological: Placebo

Sponsors: ModernaTX, Inc.

Recruiting

Author: